TY - JOUR
T1 - Prior myocarditis and ventricular arrhythmias
T2 - The importance of scar pattern
AU - Casella, Michela
AU - Bergonti, Marco
AU - Narducci, Maria Lucia
AU - Persampieri, Simone
AU - Gasperetti, Alessio
AU - Conte, Edoardo
AU - Catto, Valentina
AU - Carbucicchio, Corrado
AU - Guerra, Federico
AU - Pontone, Gianluca
AU - Andreini, Daniele
AU - Basso, Cristina
AU - Di Biase, Luigi
AU - Santangeli, Pasquale
AU - Natale, Andrea
AU - Pelargonio, Gemma
AU - Russo, Antonio Dello
AU - Tondo, Claudio
N1 - Publisher Copyright:
© 2020 Heart Rhythm Society
PY - 2021/4
Y1 - 2021/4
N2 - Background: Multiple studies have addressed the importance of anteroseptal scar in patients with nonischemic cardiomyopathy. However, this pattern has never been fully evaluated in patients with prior myocarditis. Objective: The purpose of this study was to evaluate whether anteroseptal scar is associated with worse outcome in patients with prior myocarditis and how it affects the efficacy of catheter ablation (CA). Methods: This was a retrospective study of consecutive patients with prior myocarditis and arrhythmic presentation. Cardiac magnetic resonance and electroanatomic voltage mapping were used to identify the scar pattern. Patients were referred for either CA or escalated antiarrhythmic drug (AAD) therapy. The main outcome was ventricular arrhythmia (VA)–free survival according to the presence of anteroseptal scar. Results: A total of 144 consecutive patients with prior myocarditis were included. Mean age was 42.1 ± 14.9 years, and 58% were men. Ejection fraction was normal in 73% of patients. Anteroseptal scar was present in 44% of cases. Sixty-one patients (42%) underwent CA. Overall, at 2-year follow-up, VA-free survival was 77% in the CA group. After CA, the mean number of AADs taken by each patient decreased from 1.8 to 0.9 per day (p<0.001). The presence of anteroseptal scar was found to be an independent predictor of VA relapse both in patients treated with CA (hazard ratio [HR] 3.6; 95% confidence interval [CI] 1.1–11.4; P =.03) and in the overall population (HR 2.0; 95% CI 1.2–3.5; P =.02). Conclusion: In patients with prior myocarditis and VA, the presence of anteroseptal scar negatively predicts outcomes irrespective of treatment strategy.
AB - Background: Multiple studies have addressed the importance of anteroseptal scar in patients with nonischemic cardiomyopathy. However, this pattern has never been fully evaluated in patients with prior myocarditis. Objective: The purpose of this study was to evaluate whether anteroseptal scar is associated with worse outcome in patients with prior myocarditis and how it affects the efficacy of catheter ablation (CA). Methods: This was a retrospective study of consecutive patients with prior myocarditis and arrhythmic presentation. Cardiac magnetic resonance and electroanatomic voltage mapping were used to identify the scar pattern. Patients were referred for either CA or escalated antiarrhythmic drug (AAD) therapy. The main outcome was ventricular arrhythmia (VA)–free survival according to the presence of anteroseptal scar. Results: A total of 144 consecutive patients with prior myocarditis were included. Mean age was 42.1 ± 14.9 years, and 58% were men. Ejection fraction was normal in 73% of patients. Anteroseptal scar was present in 44% of cases. Sixty-one patients (42%) underwent CA. Overall, at 2-year follow-up, VA-free survival was 77% in the CA group. After CA, the mean number of AADs taken by each patient decreased from 1.8 to 0.9 per day (p<0.001). The presence of anteroseptal scar was found to be an independent predictor of VA relapse both in patients treated with CA (hazard ratio [HR] 3.6; 95% confidence interval [CI] 1.1–11.4; P =.03) and in the overall population (HR 2.0; 95% CI 1.2–3.5; P =.02). Conclusion: In patients with prior myocarditis and VA, the presence of anteroseptal scar negatively predicts outcomes irrespective of treatment strategy.
KW - Anteroseptal scar
KW - Cardiac magnetic resonance
KW - Catheter ablation
KW - Electroanatomic voltage mapping
KW - Prior myocarditis
KW - Ventricular arrhythmia
UR - http://www.scopus.com/inward/record.url?scp=85100639751&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100639751&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2020.12.016
DO - 10.1016/j.hrthm.2020.12.016
M3 - Article
C2 - 33348060
AN - SCOPUS:85100639751
SN - 1547-5271
VL - 18
SP - 589
EP - 596
JO - Heart Rhythm
JF - Heart Rhythm
IS - 4
ER -